{"id":"https://openalex.org/W4400824466","doi":"https://doi.org/10.1016/j.jid.2024.06.1268","title":"LB1011 Cost and access changes with TNFa inhibitor biosimilars entering the market","display_name":"LB1011 Cost and access changes with TNFa inhibitor biosimilars entering the market","alternate_titles":[],"publication_year":2024,"publication_date":"2024-07-19","ids":{"openalex":"https://openalex.org/W4400824466","doi":"https://doi.org/10.1016/j.jid.2024.06.1268"},"language":"en","primary_location":{"id":"doi:10.1016/j.jid.2024.06.1268","doi":"https://doi.org/10.1016/j.jid.2024.06.1268","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jid.2024.06.1268","pdf_url":"http://www.jidonline.org/article/S0022202X24017251/pdf","source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4400824466"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.jidonline.org/article/S0022202X24017251/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083049470","display_name":"Joseph Visingardi","orcid":"https://orcid.org/0000-0001-7315-9002","observed_orcids":["https://orcid.org/0000-0001-7315-9002"]},"institutions":[{"id":"https://openalex.org/I77920804","display_name":"Albany Medical Center Hospital","ror":"https://ror.org/0307crw42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4405259726","https://openalex.org/I77920804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.V. Visingardi","raw_affiliation_strings":["Albany Medical Center, Albany, New York, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albany Medical Center, Albany, New York, United States","institution_ids":["https://openalex.org/I77920804"]}]},{"author_position":"last","author":{"id":null,"display_name":"B. Sherwood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289422878","display_name":"Dartmouth\u2013Hitchcock Medical Center","ror":"https://ror.org/00d1dhh09","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I107672454","https://openalex.org/I1289422878","https://openalex.org/I4390039337"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Sherwood","raw_affiliation_strings":["Dermatology, Dartmouth Medical Center, Lebanon, New Hampshire, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology, Dartmouth Medical Center, Lebanon, New Hampshire, United States","institution_ids":["https://openalex.org/I1289422878"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3400,"currency":"USD","value_usd":3400},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"144","issue":"8","first_page":"S178","last_page":"S178"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.75,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.75,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.24779999256134033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.871999979019165},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.9259999990463257},{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9929999709129333},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.7480000257492065},{"id":"https://openalex.org/keywords/patent-expiration","display_name":"patent expiry","score":0.640999972820282},{"id":"https://openalex.org/keywords/medicare-spending","display_name":"Medicare spending","score":0.8579999804496765},{"id":"https://openalex.org/keywords/unit-cost","display_name":"unit cost","score":0.6449999809265137},{"id":"https://openalex.org/keywords/drug-use-trends","display_name":"drug use trends","score":0.3269999921321869}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9702316522598267},{"id":"https://openalex.org/C2779722408","wikidata":"https://www.wikidata.org/wiki/Q1536078","display_name":"TNF inhibitor","level":4,"score":0.5945151448249817},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.5135107636451721},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4802256226539612},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3943706452846527},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3131468892097473},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2420939803123474},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.209124356508255}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jid.2024.06.1268","doi":"https://doi.org/10.1016/j.jid.2024.06.1268","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jid.2024.06.1268","pdf_url":"http://www.jidonline.org/article/S0022202X24017251/pdf","source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jid.2024.06.1268","doi":"https://doi.org/10.1016/j.jid.2024.06.1268","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jid.2024.06.1268","pdf_url":"http://www.jidonline.org/article/S0022202X24017251/pdf","source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.504800021648407,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400824466.pdf","grobid_xml":"https://content.openalex.org/works/W4400824466.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7118092160","https://openalex.org/W4401631114","https://openalex.org/W3166396983","https://openalex.org/W4405365584","https://openalex.org/W4393005214","https://openalex.org/W4291447972","https://openalex.org/W4401669136","https://openalex.org/W4360614862","https://openalex.org/W4401054500","https://openalex.org/W4399699830"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4400824466","counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2024-07-20T00:00:00"}
